Meeting
2013 ASCO Annual Meeting
High-dose omega-3 fatty acid supplementation to modulate breast tissue biomarkers in premenopausal women at high risk for development of breast cancer.
Authors
Carol J. Fabian
University of Kansas Medical Center, Kansas City, KS
Carol J. Fabian , Bruce F. Kimler , Brian K. Petroff , Carola Maria Zalles , Trina Metheny , Jessica A Box , Jennifer L Nydegger , Teresa A. Phillips , Brandon H Hidaka , Susan E Carlson , Linda A deGraffenried , Stephen D Hursting
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Cancer Prevention
Clinical Trial Registration Number
NCT01252277
Citation
J Clin Oncol 31, 2013 (suppl; abstr 1515)
DOI
10.1200/jco.2013.31.15_suppl.1515
Abstract #
1515
Poster Bd #
8
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Randomized double-blind placebo-controlled biomarker modulation study of vitamin d in premenopausal women at high risk for breast cancer (SWOG S0812).
First Author: Katherine D Crew
Poster
2016 ASCO Annual Meeting
Impact of a pre-operative exercise intervention on Ki-67 and metabolic markers in women with early breast cancer.
First Author: Jennifer A. Ligibel
Poster
2022 ASCO Annual Meeting
Estradiol (E2) levels in premenopausal women with hormone receptor-positive (HR+) breast cancer (BC) on ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHa).
First Author: Megan Elizabeth Tesch
Poster
2021 ASCO Annual Meeting
Final analysis of the PROMISE-GIM6 phase III trial assessing GnRH agonist use during chemotherapy as a strategy to preserve ovarian function in premenopausal patients with early breast cancer.
First Author: Matteo Lambertini